Freshleaf Analytics News

As medical cannabis access gets easier, governments will miss out on public health data Recent reforms at the State level in NSW and QLD mean

ANTG second Australian company to bring domestically cultivated products to market   ANTG, a NSW-based medicinal cannabis company, has announced that their first product is

Australia launches Senate inquiry into medical cannabis patient access The Australian Senate has just launched an inquiry into patient access to medical cannabis. The matter

ODC consults with industry on upcoming changes to licenses and more   The ODC has a lot on it’s plate right now – re-configuring their

Patient access to medical cannabis in Western Australia set to improve   We wrote recently about how empowering GP prescribers in QLD is partly responsible

Patient access to medical cannabis October figures released by Rhys Cohen 1. Record growth continues Another record month for medicinal cannabis approvals in Australia via

Australia’s Most Comprehensive Medicinal Cannabis Patient, Product and Pricing Analysis released FreshLeaf Analytics has released Australia’s most comprehensive medicinal cannabis Patient, Product and Pricing Analysis.

The last 2 years have seen a huge amount of speculation in Australia around medicinal cannabis stocks. A number of companies have listed on the

Australian media has in recent years reported on the high costs of medicinal cannabis (also known as medicinal marijuana), quoting numbers as high as $40K